Methyl iodide → 1-{[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}-4-iodo-5-methyl-1H-pyrazole
Reaktionsgleichung
[CH3:1][C:2]1([CH3:14])[O:6][C@H:5]([CH2:7][N:8]2[CH:12]=[C:11]([I:13])[CH:10]=[N:9]2)[CH2:4][O:3]1.[CH2:15]1COCC1.[Li+].CC([N-]C(C)C)C.C1CCCCC1.CI.[NH4+].[Cl-]>>[CH3:1][C:2]1([CH3:14])[O:6][C@H:5]([CH2:7][N:8]2[C:12]([CH3:15])=[C:11]([I:13])[CH:10]=[N:9]2)[CH2:4][O:3]1Komponenten
Edukt 6
Produkt 1
Versuchsvorschrift
To a solution of 1-{[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]methyl}-4-iodo-1H-pyrazole (500 mg, 1.62 mmol) in THF (4 mL, 50 mmol), cooled to −78° C., was added 1.5 M of LDA in cyclohexane (3.25 mL, 4.87 mmol). After stirring for 1 h, methyliodide (1.01 mL, 16.2 mmol) was added slowly, and the mixture was stirred at −78° C. for 1 h. Sat. NH4Cl was added to quench, and the organic solvent was removed in vacuo. The material was extracted with DCM and water, and the organic layer was concentrated in vacuo. The material was purified via column chromatography, eluting with 5-10% EtOAc/hexanes. The fractions containing the pure product were concentrated in vacuo to afford the title compound as a white solid. MS (ES+): m/z=323.06 (100) [MH+]. HPLC: tR=1.20 min (polar—3 min, UPLC-ACQUITY).
Aufarbeitung
- stirringthe mixture was stirred at −78° C. for 1 h
- customto quench
- customthe organic solvent was removed in vacuo
- extractionThe material was extracted with DCM and water
- concentrationthe organic layer was concentrated in vacuo
- customThe material was purified via column chromatography
- washeluting with 5-10% EtOAc/hexanes
- additionThe fractions containing the pure product
- concentrationwere concentrated in vacuo
Quellen und Nachweise
- ORD-Eintrag
- ord-562bb94c2aea4c85b814f4bdd4218b21
- Quelldatensatz
- uspto-grants-2013_05
- Patentnummer
- US08445510B2
Notizen zur Reaktion
Wird geladen…